BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 25221334)

  • 21. Sensor-based electromagnetic navigation to facilitate implantation of left ventricular leads in cardiac resynchronization therapy.
    Döring M; Sommer P; Rolf S; Lucas J; Breithardt OA; Hindricks G; Richter S
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):167-75. PubMed ID: 25229158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular pacing site separation by cardiac computed tomography: validation for the prediction of clinical response to cardiac resynchronization therapy.
    Modi S; Yee R; Scholl D; Stirrat J; Wong JA; Lydell C; Kotha V; Gula LJ; Skanes AC; Leong-Sit P; McCarty D; Drangova M; White JA
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1433-1442. PubMed ID: 28357725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An exploratory study on coronary sinus lead tip three-dimensional trajectory changes in cardiac resynchronization therapy.
    Tomasi C; Corsi C; Turco D; Severi S
    Heart Rhythm; 2013 Sep; 10(9):1360-7. PubMed ID: 23851066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.
    Shetty AK; Duckett SG; Ginks MR; Ma Y; Sohal M; Bostock J; Kapetanakis S; Singh JP; Rhode K; Wright M; O'Neill MD; Gill JS; Carr-White G; Razavi R; Rinaldi CA
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):692-9. PubMed ID: 23175695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.
    Lustgarten DL; Crespo EM; Arkhipova-Jenkins I; Lobel R; Winget J; Koehler J; Liberman E; Sheldon T
    Heart Rhythm; 2015 Jul; 12(7):1548-57. PubMed ID: 25828601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
    Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
    Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Bouchelouche K; Nielsen JC
    Trials; 2018 Nov; 19(1):600. PubMed ID: 30382923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of left ventricular lead position relative to scar location on response to cardiac resynchronization therapy: a model study.
    Huntjens PR; Walmsley J; Ploux S; Bordachar P; Prinzen FW; Delhaas T; Lumens J
    Europace; 2014 Nov; 16 Suppl 4():iv62-iv68. PubMed ID: 25362172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic Prediction of Cardiac Resynchronization Therapy Response Requires Analysis of Both Mechanical Dyssynchrony and Right Ventricular Function: A Combined Analysis of Patient Data and Computer Simulations.
    van Everdingen WM; Walmsley J; Cramer MJ; van Hagen I; De Boeck BWL; Meine M; Delhaas T; Doevendans PA; Prinzen FW; Lumens J; Leenders GE
    J Am Soc Echocardiogr; 2017 Oct; 30(10):1012-1020.e2. PubMed ID: 28801203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
    Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.